Shanghai Chest Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1957-01-01
- Employees
- -
- Market Cap
- -
Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
Phase 3
- Conditions
- Esophageal Neoplasms
- Interventions
- Other: Control group (Surgery alone)Drug: Adjuvant chemotherapy (Paclitaxel and Cisplatin)Radiation: Adjuvant radiotherapy
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2016-09-07
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 486
- Registration Number
- NCT02891083
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Cellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLC
Phase 2
- Conditions
- Non Small Cell Lung Cancer
- Interventions
- Biological: chemotherapy followed dendritic cells
- First Posted Date
- 2016-02-01
- Last Posted Date
- 2016-02-01
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT02669719
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Percutaneous Cryoablation Peripheral Lung Cancer
Not Applicable
- Conditions
- Lung Cancer
- Interventions
- Procedure: Percutaneous cryoablation
- First Posted Date
- 2016-01-27
- Last Posted Date
- 2016-02-12
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT02665390
UTB-VBN-EBUS With or Without Fluoroscopy for the Diagnosis of PPLs
Not Applicable
Completed
- Conditions
- Lung Cancer
- Interventions
- Procedure: VBNProcedure: EBUSProcedure: X-ray
- First Posted Date
- 2016-01-27
- Last Posted Date
- 2018-10-02
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT02664259
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
The Safety and Efficacy of Tolvaptan for Patients With Tricuspid Regurgitation and Right Heart Failure After Left Heart Valves Replacement
Phase 4
Completed
- Conditions
- Tricuspid RegurgitationRight Heart Failure
- Interventions
- Drug: tolvaptan+torasemideDrug: placebo+torasemide
- First Posted Date
- 2016-01-01
- Last Posted Date
- 2016-12-20
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02644616
- Locations
- 🇨🇳
FangYuan, Shanghai, Shanghai, China
Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)
Phase 2
- Conditions
- Brain MetastasesNon-Small Cell Lung CancerEGFR Gene Mutation
- Interventions
- Radiation: WBRT
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2015-01-26
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 210
- Registration Number
- NCT02338011
- Locations
- 🇨🇳
Varian linear accelerato, Shanghai, Shanghai, China
ENB-GS-TBLB for the Diagnosis of PPLs
Not Applicable
Completed
- Conditions
- Lung Cancer
- Interventions
- Procedure: ENBProcedure: GS-TBLB-X-ray
- First Posted Date
- 2014-08-04
- Last Posted Date
- 2015-11-30
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT02207478
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
EBUS-GS-TBLB With or Without Fluoroscopy for the Diagnosis of PPLs
Not Applicable
- Conditions
- Lung Cancer
- Interventions
- Procedure: EBUS-GSProcedure: X-ray
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2013-07-31
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01895166
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, China
Recombinant BNP on Heart and Renal Function in Acute Heart Failure
Phase 2
- Conditions
- Acute Heart FailureAcute Renal Failure
- Interventions
- Drug: standard of care
- First Posted Date
- 2012-06-21
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Shanghai Chest Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01625403
- Locations
- 🇨🇳
Shanghai Chest Hospital, Shanghai, Shanghai, China
Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy
- Conditions
- Non-small Cell Lung Cancer
- First Posted Date
- 2011-02-16
- Last Posted Date
- 2011-02-16
- Lead Sponsor
- Shanghai Chest Hospital
- Registration Number
- NCT01297101
© Copyright 2025. All Rights Reserved by MedPath